Neurologist Dr. Beth Rapaport Joins Scarsdale Medical Group
White Plains, N.Y. (March 1, 2024) – White Plains Hospital has announced that Dr. Beth Rapaport, who is board-certified in neurology and epilepsy, has joined Scarsdale Medical Group’s practice in Harrison, N.Y.
She treats a variety of neurologic conditions including epilepsy, headache, migraine, Parkinson’s disease, dementia, neuropathy and spinal radiculopathies.
Dr. Rapaport received her medical degree from New York University. She completed a residency in Neurology at Mount Sinai Medical Center, where she was chief resident, and a fellowship in Epilepsy at Cornell University Medical Center.
Dr. Rapaport has expertise in the interpretation of EEGs.
She is proficient in Spanish.
To make an appointment, call 914-723-8100.
About White Plains Hospital
White Plains Hospital is a proud member of the Montefiore Health System, serving as its tertiary hub of advanced care in the Hudson Valley. The Hospital is a 292-bed not-for-profit health care organization with the primary mission of providing exceptional acute and preventive medical care to all people who live in, work in or visit Westchester County and its surrounding areas. White Plains Hospital has outpatient medical facilities across Westchester, including multispecialty practices in Armonk, Hawthorne, Larchmont, New Rochelle, Rye Brook, Somers, Yonkers and Yorktown Heights; and Scarsdale Medical Group locations in Harrison and Scarsdale.
The Hospital is fully accredited by the Joint Commission and in 2023, White Plains Hospital received another 5-star rating from the Centers for Medicare and Medicaid Services (CMS) — the highest distinction offered by that federal agency for the second consecutive year. In addition, the Hospital received its third Magnet® designation from the American Nurses Credentialing Center (ANCC), a distinction held by only two percent of hospitals in the country. White Plains Hospital has consistently received the Outstanding Patient Experience Award from Healthgrades®, and in 2023 was awarded an “A” Safety Grade from the Leapfrog Group for the 10th consecutive time.